Liu J - Search Results

1

Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community.

Markus R, Liu J, Ramchandani M, Landa D, Born T, Kaur P. Markus R, et al. Among authors: liu j. BioDrugs. 2017 Jun;31(3):175-187. doi: 10.1007/s40259-017-0218-5. BioDrugs. 2017. PMID: 28439817 Free PMC article. Review.

2

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab.

Liu J, Eris T, Li C, Cao S, Kuhns S. Liu J, et al. BioDrugs. 2016 Aug;30(4):321-38. doi: 10.1007/s40259-016-0184-3. BioDrugs. 2016. PMID: 27461107 Free PMC article.

3

A Framework for Integrating Biosimilars Into the Didactic Core Requirements of a Doctor of Pharmacy Curriculum.

Li E, Liu J, Ramchandani M. Li E, et al. Among authors: liu j. Am J Pharm Educ. 2017 Apr;81(3):57. doi: 10.5688/ajpe81357. Am J Pharm Educ. 2017. PMID: 28496277 Free PMC article. Review.

4

Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab.

Seo N, Polozova A, Zhang M, Yates Z, Cao S, Li H, Kuhns S, Maher G, McBride HJ, Liu J. Seo N, et al. Among authors: liu j. MAbs. 2018 May/Jun;10(4):678-691. doi: 10.1080/19420862.2018.1452580. Epub 2018 Apr 20. MAbs. 2018. PMID: 29553864 Free PMC article.

5

Scientific and statistical considerations in evaluating the analytical similarity of ABP 501 to adalimumab.

Sivendran R, Ramírez J, Ramchandani M, Liu J. Sivendran R, et al. Among authors: liu j. Immunotherapy. 2018 Aug;10(11):1011-1021. doi: 10.2217/imt-2018-0040. Epub 2018 Aug 3. Immunotherapy. 2018. PMID: 30071739 Review.

6

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab.

Hutterer KM, Polozova A, Kuhns S, McBride HJ, Cao X, Liu J. Hutterer KM, et al. Among authors: liu j. BioDrugs. 2019 Jun;33(3):321-333. doi: 10.1007/s40259-019-00350-9. BioDrugs. 2019. PMID: 30972630 Free PMC article.

7

A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501.

Markus R, McBride HJ, Ramchandani M, Chow V, Liu J, Mytych D, Fanjiang G. Markus R, et al. Among authors: liu j. Adv Ther. 2019 Aug;36(8):1833-1850. doi: 10.1007/s12325-019-00979-6. Epub 2019 Jun 10. Adv Ther. 2019. PMID: 31183781 Free PMC article. Review.

8

Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product.

Hutterer KM, Ip A, Kuhns S, Cao S, Wikström M, Liu J. Hutterer KM, et al. Among authors: liu j. BioDrugs. 2021 Sep;35(5):563-577. doi: 10.1007/s40259-021-00492-9. Epub 2021 Jul 22. BioDrugs. 2021. PMID: 34296421 Free PMC article.

9

Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product.

Saleem R, Cantin G, Wikström M, Bolton G, Kuhns S, McBride HJ, Liu J. Saleem R, et al. Among authors: liu j. Pharm Res. 2020 May 31;37(6):114. doi: 10.1007/s11095-020-02816-w. Pharm Res. 2020. PMID: 32476063 Free PMC article.

10

Targeted codon optimization improves translational fidelity for an Fc fusion protein.

Hutterer KM, Zhang Z, Michaels ML, Belouski E, Hong RW, Shah B, Berge M, Barkhordarian H, Le E, Smith S, Winters D, Abroson F, Hecht R, Liu J. Hutterer KM, et al. Among authors: liu j. Biotechnol Bioeng. 2012 Nov;109(11):2770-7. doi: 10.1002/bit.24555. Epub 2012 May 28. Biotechnol Bioeng. 2012. PMID: 22573571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results